Search results for "pharmacology_toxicology"

showing 3 items of 3 documents

A systematic review of inverse agonism at adrenoceptor subtypes

2020

As many, if not most, ligands at G protein-coupled receptor antagonists are inverse agonists, we systematically reviewed inverse agonism at the nine adrenoceptor subtypes. Except for β3-adrenoceptors, inverse agonism has been reported for each of the adrenoceptor subtypes, most often for β2-adrenoceptors, including endogenously expressed receptors in human tissues. As with other receptors, the detection and degree of inverse agonism depend on the cells and tissues under investigation, i.e., they are greatest when the model has a high intrinsic tone/constitutive activity for the response being studied. Accordingly, they may differ between parts of a tissue, for instance, atria vs. ventricles…

Cell typeDrug Inverse AgonismAdrenergic receptorDrug discoveryChemistryinverse agonismReviewpharmacology_toxicology570 Life sciencesBasal (phylogenetics)lcsh:Biology (General)Drug DevelopmentDrug developmentHumansInverse agonistAgonismReceptors Adrenergic beta-2Receptorlcsh:QH301-705.5adrenoceptorconstitutive activityNeuroscience570 Biowissenschaften
researchProduct

Network Pharmacology of Red Ginseng (Part I): Effects of Ginsenoside Rg5 at Physiological and Sub-Physiological Concentrations

2021

Numerous in vitro studies on isolated cells have been conducted to uncover the molecular mechanisms of action of Panax ginseng Meyer root extracts and purified ginsenosides. However, the concentrations of ginsenosides and the extracts used in these studies were much higher than those detected in pharmacokinetic studies in humans and animals orally administered with ginseng preparations at therapeutic doses. Our study aimed to assess: (a) the effects of ginsenoside Rg5, the major “rare” ginsenoside of Red Ginseng, on gene expression in the murine neuronal cell line HT22 in a wide range of concentrations, from 10−4 to 10−18 M, and (b) the effects of differentially expressed genes on cellular …

Pharmaceutical SciencePharmacologyArticlepharmacology_toxicologyTranscriptomechemistry.chemical_compoundGinsengtranscriptomicsPharmacy and materia medicaDrug DiscoveryGene expressionnetwork pharmacologyred ginsengRIn vitroRS1-441Gene expression profilingIPA pathwayschemistryGinsenosideApoptosisCell cultureginsenoside Rg5gene expressionMedicineMolecular MedicinePharmaceuticals
researchProduct

Network Pharmacology of Ginseng (Part II): The Differential Effects of Red Ginseng and Ginsenoside Rg5 in Cancer and Heart Diseases as Determined by …

2021

Panax ginseng C.A.Mey. is an adaptogenic plant traditionally used to enhance mental and physical capacities in cases of weakness, exhaustion, tiredness, or loss of concentration, and during recovery. According to ancient records, red ginseng root preparations enhance longevity with long-term intake. Recent pharmacokinetic studies of ginsenosides in humans and our in vitro study in neuronal cells suggest that ginsenosides are effective when their levels in blood is low—at concentrations from 10−6 to 10−18 M. In the present study, we compared the effects of red ginseng root preparation HRG80TM(HRG) at concentrations from 0.01 to 10,000 ng/mL with effects of white ginseng (WG) and purified gin…

SenescenceMicroarrayred ginseng HRG80TMPharmaceutical ScienceBiologyPharmacologyArticlepharmacology_toxicologyTranscriptometranscriptomics03 medical and health sciencesGinsengchemistry.chemical_compoundPharmacy and materia medica0302 clinical medicineImmune systemginsenoside rg5Drug DiscoveryGene expressionnetwork pharmacology030304 developmental biology0303 health sciencesred ginseng HRG80<sup>TM</sup>R3. Good healthRS1-441Gene expression profilingIPA pathwayschemistryGinsenoside030220 oncology & carcinogenesisgene expressionMedicineMolecular Medicine
researchProduct